AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...

Surveillance footage from the John F. Kennedy Center for the Performing Arts in Washington, D.C. shows the moment an American Airlines regional passenger jet collided midair with a U.S. Army Black ...

The final details of the Packers’ 22-10 loss still had 59 minutes, 53 seconds to be written, converted to historical record, but you knew it the moment Jalen Hurts took the field before Jordan Love.

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

The rise of popular weight-loss medications like Ozempic, Wegovy and Manjaro has sparked a new revolution in weight-loss solutions. However, the challenge lies in finding a trusted, affordable and ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

A new poll from The -NORC Center for Public Affairs Research looks at what U.S. adults think about weight-loss drugs like Ozempic or Wegovy. (AP Video: Laura Bargfeld) ...

A new study finds that three quarters of American adults and half of adolescents are too heavy. That's making more of us sick and creating enormous health care costs.

Good Thursday morning. This is Zack Stanton, Playbook’s deputy editor, at the helm on a grim morning here in Washington. Get in touch: [email protected]. THE DCA CRASH: Before we get to the ...

Academics Learning at Harvard can happen for every type of learner, at any phase of life.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.